BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 18560368)

  • 1. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
    Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
    Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?
    Trevaskis JL; Turek VF; Griffin PS; Wittmer C; Parkes DG; Roth JD
    Physiol Behav; 2010 May; 100(2):187-95. PubMed ID: 20206194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
    Trevaskis JL; Lei C; Koda JE; Weyer C; Parkes DG; Roth JD
    Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.
    Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD
    Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
    Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG
    Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats.
    Roth JD; Hughes H; Coffey T; Maier H; Trevaskis JL; Anderson CM
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1112-7. PubMed ID: 17698985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
    Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG
    Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats.
    Boozer CN; Leibel RL; Love RJ; Cha MC; Aronne LJ
    Metabolism; 2001 Aug; 50(8):889-93. PubMed ID: 11474475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
    Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A
    Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of body weight and carcass composition by sibutramine in rats.
    Strack AM; Shu J; Camacho R; Gorski JN; Murphy B; MacIntyre DE; Hickey GJ
    Obes Res; 2002 Mar; 10(3):173-81. PubMed ID: 11886940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats.
    Ferrer-Lorente R; Cabot C; Fernández-López JA; Remesar X; Alemany M
    Eur J Pharmacol; 2005 Apr; 513(3):243-8. PubMed ID: 15862807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin.
    Boyle CN; Rossier MM; Lutz TA
    Physiol Behav; 2011 Jul; 104(1):20-8. PubMed ID: 21550355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.
    Larsen PJ; Vrang N; Petersen PC; Kristensen P
    Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
    Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
    Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
    Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
    Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.
    Roth JD; Hughes H; Kendall E; Baron AD; Anderson CM
    Endocrinology; 2006 Dec; 147(12):5855-64. PubMed ID: 16935845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.
    Trevaskis JL; Coffey T; Cole R; Lei C; Wittmer C; Walsh B; Weyer C; Koda J; Baron AD; Parkes DG; Roth JD
    Endocrinology; 2008 Nov; 149(11):5679-87. PubMed ID: 18669592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
    Rowley HL; Butler SA; Prow MR; Dykes SG; Aspley S; Kilpatrick IC; Heal DJ
    Synapse; 2000 Nov; 38(2):167-76. PubMed ID: 11018791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys.
    Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.